fbpx

Year

2018
An international research project, headed by DNA detective Eske Willerslev from the University of Copenhagen, shows in an article in Science that populations expanded rapidly across the Americas. Ancient human bones excavated from a Brazilian stalactite cave in the 1800s by legendary Danish natural scientist P W Lund play a key role. It was more...
ipeline rapidly advancing with three clinical trials planned to initiate by early 2019, including a SPR994 Phase 3 initiation around year-end 2018 CAMBRIDGE, Mass., Nov. 08, 2018 (GLOBE NEWSWIRE) — Spero Therapeutics, Inc. (Nasdaq:SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments for multi-drug resistant (MDR) bacterial infections, today announced financial results for the...
2018 scale-up of Biom’up’s manufacturing facility near Lyon (France) completed, allowing for a larger throughput and increased shipments of devices to the US and EU markets • Six key manufacturing processes upgraded, thoroughly reviewed and approved by the FDA and EMA; a strong validation of the Company capability to efficiently execute a comprehensive and demanding...
The Lundbeck Foundation is yet again to be found at the very top of the foundation transparency barometer. A principal shareholder in large companies and distributor of considerable funding has a great responsibility to tell the world openly and honestly what it does, and how it does it. This is the philosophy behind the Lundbeck...
Cambridge, UK and Indianapolis, US – 6 November 2018: Acacia Pharma Group plc (“Acacia Pharma” or “the Company”), a pharmaceutical company developing and commercialising hospital products for US and international markets, announces that it has resubmitted its New Drug Application (NDA) for BARHEMSYS(TM) (amisulpride injection) to the US Food and Drug Administration (FDA). On 8 October, the...
Lund, Sverige, 08.00 CET, 7 november 2018 – BONESUPPORT™, ett ledande företag verksamt inom ortobiologi för behandling av hålrum i ben, avger sin delårsrapport för tredje kvartalet 2018. Framgångsrik etablering av ny distributionsstruktur i USA 1 JULI – 30 SEPTEMBER 2018 Nettoomsättningen uppgick till 14,2 MSEK (32,7), en minskning med 56%. Till följd av vår uppsägning i...
Lund, Sweden, 08.00 CET, 1 November 2018 – BONESUPPORT™, an emerging leader in orthobiologics for the management of bone voids will publish its Q3 2018 Interim Report on Wednesday 7 November 2018 at 8am CET. The Company will hold a conference call and an online presentation on the same day at 10am CET. The call...
  Copenhagen, Denmark, 31 October 2018 Ira Duarte Promoted to Chief Financial Officer of Veloxis Pharmaceuticals A/S   Veloxis Pharmaceuticals A/S (NASDAQ: VELO) today announces the promotion of Ira Duarte to Chief Financial Officer.  Ms. Duarte has served as the vice-president of finance for Veloxis Pharmaceuticals, Inc. since February 2016 where she has been responsible...
Multiple Doses of AU-011 are Well-Tolerated, with Vision Preservation Observed at 12 to 18 Months All Patients Met Preliminary Efficacy Endpoint to Date with Evidence of Biological Activity CAMBRIDGE, Mass.–(BUSINESS WIRE)– Aura Biosciences, a leader in the development of novel targeted therapies in ocular oncology, today announced that updated clinical data from its Phase 1b/2...
Company Provided Review of Ongoing Phase 2 Clinical Trial of IMR-687 Cambridge, Mass. (Business Wire) Oct. 24, 2018 – Imara Inc. today announced it presented an update on its sickle cell disease program at the Annual Sickle Cell and Thalassaemia Conference (ASCAT) held this week, October 22-24 at the Westminster Bridge, County Hall in London. Dr....
1 2 3 4 5 15

News

Parkinson-symptomer invaderede fra tarmsystemet
Parkinson’s symptoms invade from the gut
18. July 2019
Muslinge-lim som erstatning for operationstråd
Mussel glue to replace surgical sutures
17. July 2019
The Lundbeck Foundation sends medical students on research secondment to California
15. July 2019

Lundbeckfonden

Lundbeckfonden Ventures

Lundbeckfonden Emerge